RXRγ

Retinoid X receptor gamma (RXRγ, NR2B3) is a member of the nuclear receptor superfamily that functions as a ligand-activated transcription factor and an obligate heterodimerization partner for multiple nuclear receptors, including retinoic acid receptors (RARs), thyroid hormone receptors, and vitamin D receptors, thereby enhancing DNA binding and transcriptional regulation of target genes^[1][2]. RXRγ is a key component of retinoid signaling pathways that regulate cellular differentiation, metabolism, development, and tissue homeostasis^[6][3]. Mechanistically, RXRγ recognizes nuclear receptor response elements through heterodimeric complexes and contributes to transcriptional programs that mediate the biological effects of retinoids and related ligands^[1][6]. In experimental models, RXRγ has been implicated in neural and metabolic regulation, as RXRγ-deficient mice display metabolic and behavioral abnormalities, while loss of RXRγ disrupts specific neuronal functions including hippocampal synaptic plasticity and retinal cone photoreceptor patterning^[7][4][5]. Disease-associated studies further indicate that RXRG expression is reduced in non-small cell lung cancer and that RXRγ may contribute to tumor-suppressive retinoid responses in selected cancer contexts^[1]. Compared with the broadly expressed RXRα and RXRβ isoforms, RXRγ exhibits a more restricted tissue distribution, with prominent expression in brain, skeletal muscle, and cardiac muscle, supporting isoform-specific physiological functions^[7]. For experimental applications, RXRγ is pharmacologically targetable by rexinoids and selective RXR ligands, and its role as a common heterodimer partner makes it a useful model for investigating nuclear receptor crosstalk and transcriptional regulation networks^[6][7].